[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-357506-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-357506-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","population-level-trends-in-lung-cancer-mortality-and-stage-distribution-during-the-uspstf-ldct-guideline-era-a-multi-database-quasi-experimental-study","Population-Level Trends in Lung Cancer Mortality and Stage Distribution During the USPSTF LDCT Guideline Era - A Multi-Database Quasi-Experimental Study","","Temporal, population-level changes in lung-cancer incidence, stage at diagnosis, and mortality are assessed around the 2013 USPSTF recommendation for low-dose computed tomography (LDCT) screening. Adults aged 55–79 years are analyzed using CDC WONDER, Global Burden of Disease, and SEER data. Joinpoint regression and interrupted time-series models estimate pre- and post-2014 trend shifts, with counterfactual projections for observed versus expected deaths. Results show accelerated post-2014 declines, higher localized-stage proportions, and fewer distant-stage diagnoses.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/population-level-trends-in-lung-cancer-mortality-and-stage-distribution-during-the-uspstf-ldct-guideline-era-a-multi-database-quasi-experimental-study/357506/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/population-level-trends-in-lung-cancer-mortality-and-stage-distribution-during-the-uspstf-ldct-guideline-era-a-multi-database-quasi-experimental-study/357506.png","ImageObject",300,407,{"name":42,"@type":43},"Fans","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of this study on LDCT screening?","Question",{"text":63,"@type":64},"To evaluate whether the 2013 USPSTF LDCT recommendation was associated with improved population-level outcomes across the U.S., focusing on changes in incidence, stage at diagnosis, and mortality after implementation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data sources and analytic methods were used?",{"text":68,"@type":64},"The study used CDC WONDER, Global Burden of Disease, and SEER data. Joinpoint regression and interrupted time-series models assessed pre- and post-2014 trend changes, while counterfactual analyses compared observed outcomes with projections from pre-2014 trends.",{"name":70,"@type":61,"acceptedAnswer":71},"What major changes were observed after 2014?",{"text":72,"@type":64},"Mortality declines accelerated across data systems, annual mortality decreased, incidence trends declined, and SEER showed a higher proportion of localized disease and fewer distant-stage diagnoses after 2014.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},357506,1790488508,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Research Article  \n\n| Population-Level Trends in Lung Cancer Mortality and Stage Distribution During the USPSTF LDCT Guideline Era: A Multi-Database Quasi-Experimental Study | Cancer Control Volume 33: 1–13 © The Author(s) 2026 Article reuse guidelines:\u003Cbr>[sagepub.com/journals-permissions](sagepub.com/journals-permissions)\u003Cbr>[DOI: 10.1177/10732748261467137](DOI: 10.1177/10732748261467137)\u003Cbr>[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)\u003Cbr>\u003Cbr>|\n| --- | --- |\n| Kaide Xia1 and Junwen Wang2 \u003Cbr>Abstract\u003Cbr>Introduction: In 2013, the United States (U.S.) Preventive Services Task Force recommended low-dose computed tomography (LDCT) for lung-cancer screening. We assessed temporal, population-level changes in incidence, stage at diagnosis, and mortality before and after this recommendation among adults aged 55–79 years. Methods: Using the US Centers for Disease Control and Prevention Wide-ranging Online Data WONDER (CDC WONDER), Global Burden of Disease (GBD), and SEER data, we examined age-adjusted incidence (AAIR) and mortality (AAMR) trends. Joinpoint regression and interrupted time-series (ITS) models evaluated pre- and post-2014 changes in population-level trends; counterfactual analyses estimated differences between observed outcomes and projections based on pre-2014 trends. SEER was used to characterize stage distributions (localized, regional, distant) . Results: Post-2014 declines accelerated across data systems. Annual AAMR decreased by 3.03% in CDC WONDER and 2.58% in GBD; AAIR declined by 1.85% and 2.37%, respectively. SEER showed a higher proportion of localized disease and fewer distant-stage diagnoses after 2014; joinpoint analyses identified a 2013 inflection with steeper declines in distant-stage incidence thereafter. In models extrapolating pre-2014 trends to subsequent years, observed deaths were lower than counterfactual projections by 28,168 in CDC WONDER and 6,906 in GBD. As an exploratory indicator, mortality-to-incidence ratios declined nationally and in both sexes. Conclusions: During the USPSTF LDCT guideline era, independent national datasets showed accelerated mortality declines and a shift toward localized-stage diagnoses. These convergent findings are temporally consistent with real-world benefits of LDCT screening, but they should be interpreted within a broader context that includes continued reductions in smoking, gradual screening uptake, and major therapeutic advances. The findings are hypothesis-generating and do not estimate the isolated causal effect of LDCT screening.\u003Cbr>Plain Language Summary\u003Cbr>Why was this study done? Lung cancer is the leading cause of cancer death worldwide. To reduce these deaths, United States health officials issued a major recommendation in 2013: adults aged 55–79 with a history of heavy smoking should undergo annual screening using Low-Dose Computed Tomography (LDCT). The goal of this policy was to catch tumors early when they are curable. We wanted to see if this national recommendation actually led to better outcomes for patients across the country. What did we do? We analyzed data from three massive national databases (CDC WONDER, Global Burden of Disease, and SEER) covering millions of Americans. We compared trends in lung cancer cases and deaths from before the |  |\n| 1Laboratory of Molecular Genetic Diagnostics, Guiyang Maternal and Child Health Care Hospital, Guiyang Children’s Hospital, Guiyang, Guizhou Province, China\u003Cbr>2Department of Psychosomatic Medicine, The Second People’s Hospital of Guiyang, Guiyang, Guizhou Province, China\u003Cbr>Corresponding author:\u003Cbr>Junwen Wang, Department of Psychosomatic Medicine, The Second People’s Hospital of Guiyang, No. 547 Jinyang South Road, Guanshanhu District, Guiyang 550081, Guizhou Province, China.\u003Cbr>[Email:](Email: wjunw1206@163.com)[ wjunw1206@163.com](Email: wjunw1206@163.com) |  |\n\nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAtt","cbCaidO1HpFpO6Ae","https://ap.wps.com/l/cbCaidO1HpFpO6Ae","pdf",2345924,13,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusions\n# Plain Language Summary\n# Keywords","[{\"question\":\"What was the purpose of this study on LDCT screening?\",\"answer\":\"To evaluate whether the 2013 USPSTF LDCT recommendation was associated with improved population-level outcomes across the U.S., focusing on changes in incidence, stage at diagnosis, and mortality after implementation.\"},{\"question\":\"Which data sources and analytic methods were used?\",\"answer\":\"The study used CDC WONDER, Global Burden of Disease, and SEER data. Joinpoint regression and interrupted time-series models assessed pre- and post-2014 trend changes, while counterfactual analyses compared observed outcomes with projections from pre-2014 trends.\"},{\"question\":\"What major changes were observed after 2014?\",\"answer\":\"Mortality declines accelerated across data systems, annual mortality decreased, incidence trends declined, and SEER showed a higher proportion of localized disease and fewer distant-stage diagnoses after 2014.\"}]","Population-Level Trends in Lung Cancer Mortality and Stage Distribution During the USPSTF LDCT Guideline Era - A Multi-Database Quasi-Experimental Study | PDF",1790130204,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8fb1c5ce4627b5fbfec3abfba14e761.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2954adf91b8f3e45ddc08c3177b1325b.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30744ecde259b91eefdb5a9bc8cb8edb.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff8e7b6d9bbfce3cf6079f7444a7a2c7.webp",980,1306]